1GA
RDY icon

1st Global Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

1st Global Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-23,070
Closed -$295K – 473
2015
Q3 		$295K Buy
23,070
+685
+3% +$8.51K 0.05% 316
2015
Q2 		$248 Buy
22,385
+1,325
+6% +$14.6K 0.04% 388
2015
Q1 		$241K Buy
21,060
+345
+2% +$3.66K 0.04% 397
2014
Q4 		$209K Buy
+20,715
New +$218K 0.03% 426

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

1st Global Advisors's RDY Position: Q4 2015 in Review

1st Global Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 23,070 shares — an estimated $295K sold.

1st Global Advisors first reported a position in RDY in Q4 2014 and held it in 4 quarters. The position peaked at $295K in Q3 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • 1st Global Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • 1st Global Advisors sold 23,070 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $295K.
  • 1st Global Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 4 quarters.
  • 1st Global Advisors's Dr. Reddy's Laboratories position peaked at $295K in Q3 2015.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on 1st Global Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.